800 Results
Sort By:
Published on October 18, 2023
Daniel Judge, MDDirector of the Cardiovascular Genetics Program and Fellowship Director for Cardiovascular DiseaseThe Medical University of South Carolina (MUSC) When Daniel Judge, MD, director of the Cardiovascular Genetics program and fellowship director for cardiovascular disease at The Medical University of South Carolina (MUSC), moved over…
Published on October 3, 2023
Genomics England has published an initial list of over 200 rare conditions that will be screened as a part of its new Generation Study, a program aimed at understanding whether sequencing babies’ genomes through newborn screening can help discover and treat rare genetic conditions earlier. The study will analyze the DNA of over 100,000…
Published on October 2, 2023
New data presented Sunday at the American Society for Radiation Oncology (ASTRO) Annual Meeting shows that precision medicine navigators (PMNs) increased the rate of genetic testing in Black prostate cancer patients six-fold. The findings have the potential to significantly reduce the health inequities and improve health outcomes for black patients.…
Published on September 18, 2023
Evidence-based, consensus guidelines for genetic testing and counseling for patients with amyotrophic lateral sclerosis (ALS) have been created. The 35 guideline statements are published in Annals of Clinical and Translational Neurology and include the new recommendation that all persons with ALS be offered comprehensive genetic testing. This, the authors said, will…
Published on August 21, 2023
An international study has sequenced the genomes of 100 infants with unexplained seizures, along with their parents to better understand the potential strengths of early, broad genome sequencing for infantile epilepsy. The researchers used rapid genome sequencing to investigate the impact of an expedited genetic diagnosis on care for the…
Published on August 8, 2023
Since the completion of the human genome project, it has been increasingly attractive for researchers to set up biobanks to collect a range of biological samples and carry out large scale genetic and genomic analyses. Relatively rare 20 years ago, there are now estimated to be more than 120 biobanks…
Published on June 27, 2023
St. Luke’s University Health Network and population health company Helix announced they will partner in a population genomics research program that seeks to enroll 100,000 St. Luke’s patients in Pennsylvania and New Jersey over the next four years. The program will provide genetic testing services to the patients as a…
Published on June 21, 2023
Sporting an all-star team of scientific founders that includes Charles Chiu, MD, PhD, Joe DeRisi, PhD, Michael Wilson, MD, Pardis Sabeti, MD, DPhil, and Matthew Meyerson, MD, PhD, Delve Bio announced its launch via a $35 million Series A financing that will help commercialize its metagenomic sequencing platform for infectious…
Published on June 5, 2023
Sponsored content brought to you by Amélie Martinez, With IVDR coming into force in the EU, there has been a lack of clarity as to what it means and whom it will impact. IPM spoke with Amélie Martinez, who has been leading Saphetor’s preparations for IVDR,…
Published on June 1, 2023
Oncology-focused real-world evidence (RWE) company ConcertAI and molecular science and technology company Caris Life Sciences announced they will develop a clinico-genomic data platform that combines comprehensive molecular profiling data with reference-standard clinical data to enable precision oncology research. The partnership expands on an agreement reached by the companies in January…
Published on May 3, 2023
Originally Aired: May 18, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET VIEW NOW SHORTLY To be implemented in the clinic, tests must be validated and approved through a regulatory process. Coverage and procedures for mutation types vary among the many available tests. There are various methods for EGFR mutation detection,…
Published on April 17, 2023
Decisions about how to treat antimicrobial resistance can be made much faster with metagenomic sequencing than by conventional laboratory tests, new research shows. This approach could save lives and better manage care. In this study, rapid metagenomics provided accurate results within just six hours. The new research was presented at…
Published on April 12, 2023
Lung cancer is the second most commonly diagnosed cancer worldwide, after breast cancer, with over 2.2 million new cases recorded in 2020 by the World Health Organization’s International Agency for Research on Cancer. It also accounted for nearly 1.8 million deaths in that year, making it the leading cause of cancer…
Published on March 20, 2023
Sponsored content brought to you by. In February 2023, Seegene met with Dr. Marta del Pino at Eurogin, the leading international conference focused on human papilloma virus (HPV) and associated cancers, to discuss the value of HPV testing and genotyping in the new cervical cancer screening paradigm. Read on to…
Published on March 13, 2023
New research published today in JNCCN‑Journal of the National Comprehensive Care Network adds more evidence to how the lack of genomic research for people of African Ancestry continues to negatively affect efforts to reduce disparities in cancer care for this group of patients. The researchers note that this is especially…